Skip to main content
. 2022 Nov 4;1(5):pgac248. doi: 10.1093/pnasnexus/pgac248

Fig. 1.

Fig. 1.

NXT-2 immunization generates antifungal cross-reactive antibodies. (A) The NXT-2 sequence was generated to a consensus sequence with homology to KEX1 regions of Pneumocystis (PC.KEX1),Aspergillus (AF.KEX1),Candida (CA.KEX1), and Cryptococcus (CN.KEX1), by amino acid type (Clustal Omega). (B) Percent identity of each KEX1 variant against NXT-2 and the western blots developed using plasma from NHPs immunized with NXT-2a + alum or PBS + alum. Antibodies to NXT-2a bind to NXT-2 (Blot 1, lane 2), AF.KEX1 (Blot 1, lane 3), PC.KEX1 (Blot 1, lane 4), and CA.KEX1 (Blot 1, lane 5). Antibodies to NXT-2a further bind to Histoplasma capsulatum KEX1 (HC.KEX2; Blot 2, lane 3), Coccidioides immitis KEX1 (CI.KEX1; Blot 1, lane 4), Mucor circinelloides KEX1 (MC.KEX1; Blot 1, lane 5), Candida auris KEX1 (CAu.KEX1; Blot 1, lane 3), and C. neoformans KEX1 (CN.KEX1; Blot 1, lane 4). (C) The correlation of % identity and the % western blot saturation quantified by ImageJ relative to NXT-2 (P = 0.0009).